Elizabeth Brunner

Elizabeth Brunner has extensive work experience in the pharmaceutical industry. Elizabeth currently holds the position of Senior Director, US Medical Affairs, Franchise Lead at Otsuka Pharmaceutical Companies (U.S.). Prior to this, they worked at Lundbeck, where they held several roles including Sr Medical Director Psychiatry Strategy and Field Medical, Sr. Medical Director Psychiatry, Medical Director Migraine, and Medical Director Schizophrenia. Before joining Lundbeck in 2018, Elizabeth worked as a Consultant at Pfizer. Elizabeth'searlier experience includes positions at Eli Lilly and Company, where they served as Sr. Medical Director Neuroscience USA, Medical Director USA Cymbalta, Strattera, Zyprexa, Sr. Medical Advisor Global Psychosis Medical Team, Sr. Medical Advisor, Global Patient Safety, Chief Safety Officer, Clinical Research Physician-Neuroscience, and Clinical Research Scientist. Elizabeth also has experience in private practice clinical psychiatry at Grupo Médico Carracci.

Elizabeth Brunner completed their Doctor of Medicine (M.D.) degree in Medicine at Escuela Mexicana de Medicina La Salle from 1985 to 1992. Elizabeth then pursued a Specialty degree in Psychiatry through the Psychiatry Residency Program at the Instituto Nacional de Psiquiatria Ramon de la Fuente from 1992 to 1995. Later on, Elizabeth returned to the Instituto Nacional de Psiquiatria Ramon de la Fuente to further their studies in Psychiatry, although the specific years are unspecified.